EUVIMEDEUVIMED entdecken
Crossref

Psychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants

Won-Seok Choi, MoonSoo Lee, Mi Kyoung Seo, Og-Jin Jang, Jung Goo Lee

Clinical Psychopharmacology and Neuroscience · 31.07.2026

DOI: 10.9758/cpn.26.1457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 31.07.2026. Verfasst von Won-Seok Choi und 4 weiteren Autor:innen. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder remains a leading cause of global disability, and many patients show limited response to conventional antidepressants.Increasing evidence suggests that a substantial subgroup exhibits chronic low-grade inflammation, which may constrain synaptic plasticity and contribute to persistent depressive symptoms.In this review, we propose that depression can be conceptualized as a disorder of dysregulated inflammation-plasticity coupling, in which inflammatory signaling interferes with adaptive neural remodeling.Sterile neuroinflammation, triggered by non-infectious stressors such as psychosocial stress and metabolic dysfunction, disrupts glutamatergic transmission, reduces brain-derived neurotrophic factor signaling, and impairs synaptic plasticity.These processes may contribute to circuit rigidity, reduced neural flexibility, and treatment resistance.Psychoplastogens, including ketamine, serotonergic psychedelics, and emerging non-hallucinogenic analogues, offer a distinct therapeutic approach by rapidly enhancing synaptic plasticity.Rather than directly suppressing inflammation, these compounds may restore neural adaptability and functionally decouple plasticity-related processes from inflammatory constraints.A central contribution of this review is the integration of inflammation-plasticity coupling and relative functional decoupling as a translational framework for understanding rapid-acting antidepressant mechanisms.Within this framework, experience-independent psychoplastogens may represent a promising direction for future antidepressant development.However, such compounds should currently be regarded as an emerging drug-development strategy rather than an established therapeutic approach.Further research is needed to validate these mechanisms in humans and to optimize biomarker-guided, plasticity-focused treatment strategies for depression.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Choi, W., Lee, M., Seo, M. K., Jang, O., & Lee, J. G. (2026). Psychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants. Clinical Psychopharmacology and Neuroscience. https://doi.org/10.9758/cpn.26.1457

Vancouver

Choi W, Lee M, Seo MK, Jang O, Lee JG. Psychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants. Clinical Psychopharmacology and Neuroscience. 2026. doi:10.9758/cpn.26.1457

BibTeX
@article{Choi2026,
  author = {Choi, Won-Seok and Lee, MoonSoo and Seo, Mi Kyoung and Jang, Og-Jin and Lee, Jung Goo},
  title = {Psychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants},
  journal = {Clinical Psychopharmacology and Neuroscience},
  year = {2026},
  doi = {10.9758/cpn.26.1457}
}
Kostenlos starten →